高级检索
当前位置: 首页 > 详情页

Anti-influenza properties of tiliroside isolated from Hibiscus mutabilis L

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

机构: [1]School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China [2]College of Pharmaceutical Sciences, Hebei University, Baoding, 077000, China [3]Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (CUHK), The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China [4]SUSTech Core Research Facilities, Southern University of Science and Technology, Shenzhen, 518000, China [5]China National Analytical Center, Guangzhou Institute of Analysis, Guangdong Academy of Sciences. Guangzhou, 510000, China [6]The Second Clinical Medical College, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou, 510006, China [7]Guangzhou Key Laboratory of Chirality Research on Active Components of Traditional Chinese Medicine, Guangzhou, 510006, China [8]Guangdong Provincial Key Laboratory of Chemical Measurement and Emergency Test Technology Institute of Analysis, Guangdong Academy of Sciences, China National Analytical Center, Guangzhou, China [9]Cardiovascular Institute, School of Medicine, Stanford University, California, USA
出处:
ISSN:

关键词: Hibiscus mutabilis L Influenza virus Ribonucleoprotein

摘要:
Ethnopharmacological relevance: Fu Rong Ye (FRY), the leaf of Hibiscus mutabilis L., is a Chinese medicinal herb used to treat coughs and respiratory diseases. FRY is the major herbal component of the patent medicine Fupo Ganmao Granules for treating common cold. However, its anti-influenza active components and mechanism were not identified.Aim: Here, we aim to a) isolate the anti-influenza phytochemicals from FRY extract and b) explore its anti-flu mechanism.Material and methods: Bioassay guided isolation was performed to get anti-influenza virus components. Influenza virus infected cells and mouse model were employed for efficacy evaluation. Results: Using bioassay-guided isolation, the flavonoid tiliroside was obtained, which inhibited four IAV strains in MDCK cells with EC50 ranging from 3.87 to 27.61 mu M by suppressing the viral ribonucleoprotein activity. Tiliroside also significantly downregulated the expression of cytokines/chemokines in A549 cells, and protected 50% of PR8-infected BALB/c mice from death and at 800 mg/kg/day, improved lung edema conditions.Conclusion: Tiliroside is effective for influenza virus infection treatment and promising for further drug devel-opment. This study is the first to demonstrate that tiliroside in FRY acts against influenza virus.

基金:
语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类 | 2 区 医学
小类 | 1 区 药学 1 区 全科医学与补充医学 1 区 植物科学 2 区 药物化学
最新[2025]版:
大类 | 2 区 医学
小类 | 1 区 全科医学与补充医学 1 区 药学 2 区 药物化学 2 区 植物科学
JCR分区:
出版当年[2021]版:
Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Q1 PLANT SCIENCES Q2 CHEMISTRY, MEDICINAL Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 CHEMISTRY, MEDICINAL Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE Q1 PHARMACOLOGY & PHARMACY Q1 PLANT SCIENCES

影响因子: 最新[2023版] 最新五年平均 出版当年[2021版] 出版当年五年平均 出版前一年[2020版] 出版后一年[2022版]

第一作者:
第一作者机构: [1]School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China
共同第一作者:
通讯作者:
通讯机构: [1]School of Life Sciences, The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China [3]Li Dak Sum Yip Yio Chin R&D Centre for Chinese Medicine and State Key Laboratory of Research on Bioactivities and Clinical Applications of Medicinal Plants (CUHK), The Chinese University of Hong Kong, Shatin, N.T, 999077, Hong Kong, China [5]China National Analytical Center, Guangzhou Institute of Analysis, Guangdong Academy of Sciences. Guangzhou, 510000, China [*1]School of Life Sciences, The Chinese University of Hong Kong, Hong Kong, China [*2]China National Analytical Center, Guangzhou Institute of Analysis, Guangdong Academy of Sciences, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:2020 今日访问量:0 总访问量:646 更新日期:2024-07-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 广东省中医院 技术支持:重庆聚合科技有限公司 地址:广州市越秀区大德路111号